• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-ErbA而非v-ErbA与一种假定的红系阻遏物竞争结合碳酸酐酶II启动子。

c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.

作者信息

Rascle A, Ghysdael J, Samarut J

机构信息

Laboratoire de Biologie Moléculaire et Cellulaire, CNRS UMR49, INRA, Ecole Normale Supérieure de Lyon, France.

出版信息

Oncogene. 1994 Oct;9(10):2853-67.

PMID:7916146
Abstract

The carbonic anhydrase II (CAII) gene is the only known gene identified as direct target for v-ErbA-mediated repression in avian erythroleukemic cells transformed by Avian Erythroblastosis Virus (AEV). This gene is transcriptionally activated by thyroid hormone (T3) in normal erythrocytic cells. In this work we have analysed the molecular basis of the transcriptional control of the CAII gene by c-ErbA and v-ErbA. We show that several domains in the promoter control hormonal regulation of transcription. One domain proximal to the TATA box mediates T3 response but contains no identified binding site for c-ErbA. An other domain termed PAL2 is approximately 600 bp upstream the transcription initiation site and contains a c-ErbA binding site. We show that when it is associated to a heterologous promoter this site mediates transcriptional repression in erythrocytic cells but not in HeLa cells. Moreover, this site binds a nuclear erythrocyte-specific factor that we called NFX, which is different from c-ErbA. heterodimers between c-ErbA and the 9-cis retinoic acid receptor (RXR) compete with NFX for binding to PAL2. In contrast, v-ErbA alone or in association with RXR is a very poor competitor and is unable to chase NFX out of the PAL2 site. We propose that NFX is a transcription repressor whose activity is inhibited by c-ErbA but not v-ErbA. This mechanism might contribute to the overall regulation of the carbonic anhydrase II promoter. These data illustrate another possible mechanism through which v-ErbA might antagonize the function of c-ErbA in controlling gene expression.

摘要

碳酸酐酶II(CAII)基因是唯一已知的被确定为禽成红细胞白血病病毒(AEV)转化的禽成红细胞白血病细胞中v-ErbA介导的抑制作用直接靶点的基因。该基因在正常红细胞细胞中由甲状腺激素(T3)转录激活。在这项工作中,我们分析了c-ErbA和v-ErbA对CAII基因转录控制的分子基础。我们表明,启动子中的几个结构域控制转录的激素调节。靠近TATA框的一个结构域介导T3反应,但未发现c-ErbA的结合位点。另一个称为PAL2的结构域位于转录起始位点上游约600 bp处,包含一个c-ErbA结合位点。我们表明,当它与异源启动子相关联时,该位点在红细胞细胞中介导转录抑制,但在HeLa细胞中不介导。此外,该位点结合一种我们称为NFX的核红细胞特异性因子,它与c-ErbA不同。c-ErbA和9-顺式视黄酸受体(RXR)之间的异二聚体与NFX竞争结合PAL2。相反,单独的v-ErbA或与RXR结合时是一个非常弱的竞争者,无法将NFX从PAL2位点驱逐出去。我们提出NFX是一种转录抑制因子,其活性被c-ErbA抑制,但不被v-ErbA抑制。这种机制可能有助于碳酸酐酶II启动子的整体调节。这些数据说明了v-ErbA可能在控制基因表达中拮抗c-ErbA功能的另一种可能机制。

相似文献

1
c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.c-ErbA而非v-ErbA与一种假定的红系阻遏物竞争结合碳酸酐酶II启动子。
Oncogene. 1994 Oct;9(10):2853-67.
2
The carbonic anhydrase II gene, a gene regulated by thyroid hormone and erythropoietin, is repressed by the v-erbA oncogene in erythrocytic cells.
New Biol. 1990 Mar;2(3):284-94.
3
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.v-ErbA癌蛋白导致的白血病转化在体内需要与红系增强子持续结合并对其进行抑制。
EMBO J. 1998 Dec 15;17(24):7382-94. doi: 10.1093/emboj/17.24.7382.
4
The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.v-ErbA癌蛋白可抑制红系特异性增强子的活性。
Oncogene. 2001 Feb 15;20(7):775-87. doi: 10.1038/sj.onc.1204159.
5
The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.癌蛋白P75gag-v-erbA仅通过含有回文半位点的反应元件抑制甲状腺激素诱导的转录。
Oncogene. 1996 Aug 15;13(4):843-52.
6
V-erbA requires auxiliary proteins for dominant negative activity.V-erbA发挥显性负性活性需要辅助蛋白。
Oncogene. 1993 Jan;8(1):55-65.
7
V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
Oncogene. 1992 May;7(5):953-60.
8
Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.内源性甲状腺激素和视黄酸受体对正常红系分化的调节:v-erbA癌基因作用的一个可能靶点。
Oncogene. 1992 Feb;7(2):217-27.
9
The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.v-erbA癌基因需要与酪氨酸激酶协同作用,以阻止由配体激活的内源性c-erbA和视黄酸受体诱导的红细胞分化。
Oncogene. 1992 Feb;7(2):203-16.
10
v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
Genes Dev. 1991 Nov;5(11):2033-47. doi: 10.1101/gad.5.11.2033.

引用本文的文献

1
Large-scale analysis by SAGE reveals new mechanisms of v-erbA oncogene action.SAGE的大规模分析揭示了v-erbA癌基因作用的新机制。
BMC Genomics. 2007 Oct 26;8:390. doi: 10.1186/1471-2164-8-390.
2
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.v-ErbA癌蛋白导致的白血病转化在体内需要与红系增强子持续结合并对其进行抑制。
EMBO J. 1998 Dec 15;17(24):7382-94. doi: 10.1093/emboj/17.24.7382.
3
Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
Myb-Ets融合癌蛋白抑制甲状腺激素受体/c-ErbA和视黄酸受体功能:E26禽逆转录病毒致白血病转化的一种新作用机制。
Mol Cell Biol. 1996 Nov;16(11):6338-51. doi: 10.1128/MCB.16.11.6338.